Canterbury DHB


Drug-Induced Neutropenia

Management will depend on the severity of the neutropenia and the clinical state of the patient. This should include an assessment of their ability to care for themselves as an outpatient.

About this Canterbury DHB document (6371):

Document Owner:

Mark Smith (see Who's Who)

Issue Date:

August 2017

Next Review:

August 2019


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 6371